Cited by 182Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.

Open access

LaHoste, G J, Yu, J, Marshall, J F·1993·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.90.16.7451PMC PMC47159

Open this paper in CoChat — free account

Abstract

Immediate-early genes, such as c-fos, are responsive to dopaminergic stimulation in the brain and can have prolonged effects on the transcription of other genes. Thus, they may mediate some of the long-term consequences of altered dopaminergic transmission on striatal neurons, such as the supersensitivity to dopamine and its agonists that occurs in response to dopamine denervation. The two dopamine receptor families, D1 and D2, interact synergistically under normal conditions but independently after treatments that induce pronounced supersensitivity to dopamine agonists. Using immunocytochemical methods in rats treated with directly acting selective dopamine agonists, we have determined that dopamine-mediated expression of Fos and Fos-like antigens in the striatum normally requires concomitant stimulation of D1 and D2 receptors. Separate administration of a high dose of a selective D1 (SKF 38393; 20 mg/kg) or D2 (quinpirole; 3 mg/kg) agonist induced Fos-like immunoreactivity in few neurons, whereas combined administration of the D1 and D2 agonists produced patches of intensely stained immunoreactive nuclei in the caudate-putamen. Repeated administration of reserpine (1 mg/kg per day for 5 days), which causes supersensitivity to dopamine agonists and a breakdown in D1/D2 synergism behaviorally, also causes a change in control of c-fos, such that independent stimulation of D1 receptors by SKF 38393 (20 mg/kg) elicited pronounced Fos-like immunoreactivity in the striatum; combined treatment with SKF 38393 (20 mg/kg) and quinpirole (3 mg/kg) in reserpine-treated rats elicited Fos-like expression in no more neurons than did D1 agonism alone. These data demonstrate that dopamine-mediated Fos expression in the striatum is indicative of the state of D1/D2 synergism and receptor supersensitivity.

Integrity signals

Registry

Crossref · 10.1073/pnas.90.16.7451

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Rat Brain in Stereotaxic Coordinates
Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
Functional architecture of basal ganglia circuits: neural substrates of parallel processing
Alexander, G. E., & Crutcher, M. D. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90107-l · Cited by 4,131
Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun.
Morgan, J., & Curran, T. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.002225 · Cited by 2,689
The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia
Gerfen, C. R. (1992) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.15.030192.001441 · Cited by 1,004
Molecular biology of dopamine receptors
Sibley, D. R., & Monsma, F. J. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90025-2 · Cited by 993
Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum.
Graybiel, A. M., Moratalla, R., & Robertson, H. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6912 · Cited by 957
Regulation of Proenkephalin by Fos and Jun
Sonnenberg, J. L., Rauscher, F. J., Morgan, J. I., & Curran, T. (1989) · Science · doi:10.1126/science.2512642 · Cited by 532
Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors.
Young, S., Porrino, L. J., & Iadarola, M. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1291 · Cited by 497
Neuroleptics increase C-FOS expression in the forebrain: Contrasting effects of haloperidol and clozapine
Robertson, G. S., & Fibiger, H. C. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90054-6 · Cited by 474

Show all 35 references

Sorted by citations

Dopamine receptors: from structure to function
MISSALE, C., NASH, S. R., ROBINSON, S. W., JABER, M., & CARON, M. G. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.1.189 · Cited by 3,633
Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins
Herdegen, T., & Leah, J. D. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00018-6 · Cited by 1,369
Addiction, Dopamine, and the Molecular Mechanisms of Memory
Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,184
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models
Day, M., Wang, Z., Ding, J., An, X., Ingham, C. A., Shering, A. F., Wokosin, D., Ilijic, E., Sun, Z., Sampson, A. R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1632 · Cited by 745
D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum
Moine, C. L., & Bloch, B. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903550308 · Cited by 576
Dopamine receptors and brain function
Jaber, M., Robinson, S. W., Missale, C., & Caron, M. G. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00100-1 · Cited by 594
Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness
Scammell, T. E., Estabrooke, I. V., McCarthy, M. T., Chemelli, R. M., Yanagisawa, M., Miller, M. S., & Saper, C. B. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08620.2000 · Cited by 484
D1 Dopamine Receptor Supersensitivity in the Dopamine-Depleted Striatum Results from a Switch in the Regulation of ERK1/2/MAP Kinase
Gerfen, C. R., Miyachi, S., Paletzki, R. F., & Brown, P. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05042.2002 · Cited by 379
Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior
Steiner, H., & Gerfen, C. R. (1998) · Experimental Brain Research · doi:10.1007/s002210050545 · Cited by 365
Dopamine and N-Methyl-D- Aspartate Receptor Interactions in the Neostriatum
Cepeda, C., & Levine, M. S. (1998) · Developmental Neuroscience · doi:10.1159/000017294 · Cited by 350
Molecular effects of dopamine on striatal-projection pathways
Gerfen, C. R. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00019-7 · Cited by 356
The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction
Burkett, J. P., & Young, L. J. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2794-x · Cited by 307
“Under normal conditions, a synergistic balance of D1R- and D2R-like activation exists in striatal regions (Walters et al. 1987; LaHoste et al. 1993; Gerfen et al. 1995; Wise et al. 1996; Hu and White 1997).”
D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons
Gerfen, C., Keefe, K., & Gauda, E. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-12-08167.1995 · Cited by 283
Network-Level Changes in Expression of Inducible Fos–Jun Proteins in the Striatum during Chronic Cocaine Treatment and Withdrawal
Moratalla, R., Elibol, B., Vallejo, M., & Graybiel, A. M. (1996) · Neuron · doi:10.1016/s0896-6273(00)80288-3 · Cited by 276
RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion
Ding, J., Guzmán, J. N., Tkatch, T., Chen, S., Goldberg, J. A., Ebert, P. J., Levitt, P. R., Wilson, C. J., Hamm, H. E., & Surmeier, D. J. (2006) · Nature Neuroscience · doi:10.1038/nn1700 · Cited by 255
New technologies for examining the role of neuronal ensembles in drug addiction and fear
Cruz, F. C., Koya, E., Guez‐Barber, D., Bossert, J. M., Lupica, C. R., Shaham, Y., & Hope, B. T. (2013) · Nature reviews. Neuroscience · doi:10.1038/nrn3597 · Cited by 251
Differential Excitability and Modulation of Striatal Medium Spiny Neuron Dendrites
Day, M., Wokosin, D. L., Plotkin, J. L., Tian, X., & Surmeier, D. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.1840-08.2008 · Cited by 242
Dopamine Modulates Release from Corticostriatal Terminals
Bamford, N. S., Robinson, S., Palmiter, R. D., Joyce, J. A., Moore, C., & Meshul, C. K. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2891-04.2004 · Cited by 248
Enhancing neuroplasticity in the basal ganglia: The role of exercise in Parkinson's disease
Petzinger, G. M., Fisher, B. E., Leeuwen, J. V., Vukovic, M., Akopian, G. K., Meshul, C. K., Holschneider, D. P., Nacca, A., Walsh, J. P., & Jakowec, M. W. (2010) · Movement Disorders · doi:10.1002/mds.22782 · Cited by 217
Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Guillot, T. S., & Miller, G. W. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8059-y · Cited by 209
Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor
Moratalla, R., Xu, M., Tonegawa, S., & Graybiel, A. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14928 · Cited by 188
Using c-fos to study neuronal ensembles in corticostriatal circuitry of addiction
Cruz, F. C., Rubio, F. J., & Hope, B. T. (2014) · Brain Research · doi:10.1016/j.brainres.2014.11.005 · Cited by 173
Δ9‐tetrahydrocannabinol‐induced MAPK/ERK and Elk‐1 activation in vivo depends on dopaminergic transmission
Valjent, E., Pagès, C., Rogard, M., Besson, M., Maldonado, R. J., & Caboche, J. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01652.x · Cited by 179
The goldfish (Carassius auratus) as a model for neuroendocrine signaling
Popesku, J. T., Martyniuk, C. J., Mennigen, J. A., Xiong, H., Zhang, D., Xia, X., Cossins, A. R., & Trudeau, V. L. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.06.017 · Cited by 159
Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors
Perachon, S., Schwartz, J.-C., & Sokoloff, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00896-6 · Cited by 157
Coexpression of dopamine D1and D3receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions
Ridray, S., Griffon, N., Mignon, V., Souil, E., Carboni, S., Díaz, J., Schwartz, J.-C., & Sokoloff, P. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00173.x · Cited by 156
Effects of levodopa on endocannabinoid levels in rat basal ganglia: implications for the treatment of levodopa‐induced dyskinesias
Ferrer, B., Asbrock, N., Kathuria, S., Piomelli, D., & Giuffrida, A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02896.x · Cited by 155
Dopamine-Deficient Mice Are Hypersensitive to Dopamine Receptor Agonists
Kim, D. S., Szczypka, M. S., & Palmiter, R. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-12-04405.2000 · Cited by 144
Repetitive Behaviors in Monkeys Are Linked to Specific Striatal Activation Patterns
Saka, E., Goodrich, C. M., Harlan, P. C., Madras, B. K., & Graybiel, A. M. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1072-04.2004 · Cited by 139
Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes
Holmes, A., Lachowicz, J. E., & Sibley, D. R. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.034 · Cited by 133
The Dopamine D1–D2 Receptor Heteromer in Striatal Medium Spiny Neurons: Evidence for a Third Distinct Neuronal Pathway in Basal Ganglia
Perreault, M. L., Hasbi, A., O’Dowd, B. F., & George, S. R. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00031 · Cited by 129
Systemic administration of adenosine A2A receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study
Ochi, M., Koga, K., Kurokawa, M., Kase, H., Nakamura, J., & Kuwana, Y. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00250-5 · Cited by 128
Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance
Hasbi, A., O’Dowd, B. F., & George, S. R. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-26 · Cited by 121
D1–D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression
Keefe, K. A., & Gerfen, C. R. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00024-d · Cited by 122
Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons
Jaber, M., Cador, M., Dumartin, B., Normand, E., Stinus, L., & Bloch, B. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00537-f · Cited by 108
Concurrent Activation of Dopamine D1and D2Receptors Is Required to Evoke Neural and Behavioral Phenotypes of Cocaine Sensitization
Capper-Loup, C., Canales, J. J., Kadaba, N., & Graybiel, A. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-06218.2002 · Cited by 108
Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway
Nikkah, G., Cunningham, M., Cenci, M. A., McKay, R. D. G., & Björklund, A. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-05-03548.1995 · Cited by 103
Pathophysiology of Tourette's syndrome: striatal pathways revisited
Saka, E., & Graybiel, A. M. (2003) · Brain and Development · doi:10.1016/s0387-7604(03)90002-7 · Cited by 92
Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cyclase response element-binding protein and Fos-related antigen immunoreactivity in rat striatum
Simpson, J. N., Wang, J. Q., & McGinty, J. F. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00274-m · Cited by 91
Conditional Ablation of Striatal Neuronal Types Containing Dopamine D2 Receptor Disturbs Coordination of Basal Ganglia Function
Sano, H., Yasoshima, Y., Matsushita, N., Kaneko, T., Kohno, K., Pastan, I. H., & Kobayashi, K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09078.2003 · Cited by 84
The prevalence and clinical characteristics of punding in Parkinson's disease
Spencer, A., Rickards, H. E., Fasano, A. A., & Cavanna, A. E. (2011) · Movement Disorders · doi:10.1002/mds.23508 · Cited by 86
Absence of dopamine D2 receptors unmasks an inhibitory control over the brain circuitries activated by cocaine
Welter, M., Vallone, D., Samad, T. A., Méziane, H., Usiello, A., & Borrelli, E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610790104 · Cited by 87
Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine
Spangler, R., Goddard, N. L., Avena, N. M., Hoebel, B. G., & LEIBOWITZ, S. F. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00671-x · Cited by 80
Burst stimulation of the medial forebrain bundle selectively increases Fos-like immunoreactivity in the limbic forebrain of the rat
Chergui, K., Nomikos, G. G., Mathé, J. M., Gonon, F., & Svensson, T. H. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00513-7 · Cited by 79
Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors
Xu, W., Zhu, J. P. Q., & Angulo, J. A. (2005) · Synapse · doi:10.1002/syn.20185 · Cited by 78
Amphetamine‐ and cocaine‐induced fos in the rat striatum depends on D2 dopamine receptor activation
Ruskin, D. N., & Marshall, J. F. (1994) · Synapse · doi:10.1002/syn.890180309 · Cited by 78
Self-citation
Dopamine D1 Receptors Synergize with D2, But Not D3 or D4, Receptors in the Striatum without the Involvement of Action Potentials
LaHoste, G. J., Henry, B. L., & Marshall, J. F. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06666.2000 · Cited by 73
Self-citation
Scopolamine augments C-fos and zif/268 messenger rna expression induced by the full D1 dopamine receptor agonist SKF-82958 in the intact rat striatum
Wang, J. Q., & McGinty, J. F. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00597-8 · Cited by 73
The Full D1 Dopamine Receptor Agonist SKF-82958 Induces Neuropeptide mRNA in the Normosensitive Striatum of Rats: Regulation of D1/D2 Interactions by Muscarinic Receptors
Wang, J. Q., & McGinty, J. F. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36678-9 · Cited by 72
Regulation of gap junction coupling in the developing neocortex
Rörig, B., & Sutor, B. (1996) · Molecular Neurobiology · doi:10.1007/bf02755590 · Cited by 66
Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum
Wirtshafter, D., & Asin, K. E. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90220-8 · Cited by 61
Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression
Labandeira-García, J. L., Rozas, G., López-Martín, M. E., Liste, I., & Guerra, M. J. (1996) · Experimental Brain Research · doi:10.1007/bf00242905 · Cited by 60
The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge
Daunais, J. B., & McGinty, J. F. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00226-i · Cited by 59
Addiction-related gene regulation: Risks of exposure to cognitive enhancers vs. other psychostimulants
Steiner, H., & Waes, V. V. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.10.001 · Cited by 58
Increased Expression of NGFI‐A mRNA in the Rat Striatum Following Burst Stimulation of the Medial Forebrain Bundle
Chergui, K., Svenningsson, P., Nomikos, G. G., Gonon, F., Fredholm, B. B., & Svensson, T. H. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01654.x · Cited by 52
A novel tyrosine kinase inhibitor AMN107 (nilotinib) normalizes striatal motor behaviors in a mouse model of Parkinson’s disease
Tanabe, A., Yamamura, Y., Kasahara, J., Morigaki, R., Kaji, R., & Goto, S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00050 · Cited by 50
Cocaine-induced Fos expression in rat striatum is blocked by chloral hydrate or urethane
Kreuter, J. D., Mattson, B. J., Wang, B., You, Z. ‐., & Hope, B. T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.047 · Cited by 50
Site-specific neural hyperactivity via the activation of MAPK and PKA/CREB pathways triggers neuronal degeneration in methylmercury-intoxicated mice
Fujimura, M., & Usuki, F. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.03.001 · Cited by 48
The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine‐lesioned parkinsonian rhesus monkeys
Vermeulen, R. J., Drukarch, B., Sahadat, M. C. R., Goosen, C., Wolters, E. C., & Stoof, J. C. (1994) · Movement Disorders · doi:10.1002/mds.870090613 · Cited by 47
Identification of functional dopamine receptors in human teratocarcinoma NT2 cells
Sodja, C., Fang, H., Dasgupta, T., Ribecco, M. T. S., Walker, P. R., & Sikorska, M. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00324-2 · Cited by 46
Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: Interhemispheric effects
Yano, M., Beverley, J. A., & Steiner, H. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.017 · Cited by 46
Reversal of supersensitive striatal dopamine D1 receptor signaling and extracellular signal-regulated kinase activity in dopamine-deficient mice†
Kim, D. S., Palmiter, R. D., Cummins, A. C., & Gerfen, C. R. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.10.054 · Cited by 45
Screening the dopamine D1 receptor gene in 131 schizophrenics and eight alcoholics: Identification of polymorphisms but lack of functionally significant sequence changes
Liu, Q., Sobell, J. L., Heston, L. L., & Sommer, S. S. (1995) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320600216 · Cited by 44
Mapping the Effects of Three Dopamine Agonists with Different Dyskinetogenic Potential and Receptor Selectivity Using Pharmacological Functional Magnetic Resonance Imaging
Delfino, M., Kalisch, R., Czisch, M., Larramendy, C., Ricatti, M. J., Taravini, I. R. E., Trenkwalder, C., Murer, M. G., Auer, D. P., & Gershanik, O. S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301329 · Cited by 43
Cerebrocortical Fos expression following dopaminergic stimulation: D1/D2 synergism and its breakdown
LaHoste, G. J., Ruskin, D. N., & Marshall, J. F. (1996) · Brain Research · doi:10.1016/0006-8993(96)00392-7 · Cited by 42
Self-citation
Dopamine D2 receptor control of pallidal fos expression: comparisons between intact and 6-hydroxydopamine-treated hemispheres
Marshall, J. F., Cole, B. N., & LaHoste, G. J. (1993) · Brain Research · doi:10.1016/0006-8993(93)91166-p · Cited by 42
Self-citation
Effects of Individual and Concurrent Stimulation of Striatal D1 and D2 Dopamine Receptors on Electrophysiological and Behavioral Output from Rat Basal Ganglia
Waszczak, B. L., Martin, L. P., Finlay-Morreale, H., Zahr, N. M., & Stellar, J. R. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.850 · Cited by 40
Regulation of c-Jun N-Terminal Kinase by the ORL1Receptor through Multiple G Proteins
Chan, A. S. L., & Wong, Y. H. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39010-x · Cited by 38
Co-stimulation of D1/D5 and D2 dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons
Svenningsson, P., Fredholm, B. B., Bloch, B., & Moine, C. L. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00155-x · Cited by 38
Coactivation of D1 and D2 Dopamine Receptors: In Marriage, a Case of His, Hers, and Theirs
Pollack, A. E. (2004) · Science s STKE · doi:10.1126/stke.2552004pe50 · Cited by 37
Time‐dependent changes in dopamine agonist‐induced striatal fos immunoreactivity are related to sensory neglect and its recovery after unilateral prefkontal cortex injury
Vargo, J. M., & Marshall, J. F. (1995) · Synapse · doi:10.1002/syn.890200404 · Cited by 37
Self-citation
The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens
Yamada, H., Kuroki, T., Nakahara, T., Hashimoto, K., Tsutsumi, T., Hirano, M., & Maeda, H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.11.011 · Cited by 36
Natural Sympathomimetic Drugs: From Pharmacology to Toxicology
Costa, V. M., Rossato‐Grando, L. G., Milandri, E., Nardi, J., Teixeira, P., Mladěnka, P., Remião, F., & OEMONOM, O. B. O. T. (2022) · Biomolecules · doi:10.3390/biom12121793 · Cited by 36
Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment
Saka, E., Elibol, B., Erdem‐Özdamar, S., & Dalkara, T. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01231-7 · Cited by 33
Dopaminergic modulation of neuronal activity in the monkey putamen through D1 and D2 receptors during a delayed Go/Nogo task
Inase, M., Li, B., & Tanji, J. (1997) · Experimental Brain Research · doi:10.1007/s002210050217 · Cited by 34
Dopamine-Dependent Desensitization of Dopaminergic Signaling in the Developing Mouse Striatum
Kim, D. S., Froelick, G. J., & Palmiter, R. D. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09841.2002 · Cited by 34
The action of pulse‐modulated GSM radiation increases regional changes in brain activity and c‐Fos expression in cortical and subcortical areas in a rat model of picrotoxin‐induced seizure proneness
López-Martín, M. E., Bregains, J. C., Relova-Quinteiro, J. L., Cadarso-Suárez, C., Jorge‐Barreiro, F. J., & Ares‐Pena, F. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21951 · Cited by 33
Rapid development of D1 and D2 dopamine receptor supersensitivity as indicated by striatal and pallidal Fos expression
LaHoste, G. J., & Marshall, J. F. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90957-1 · Cited by 33
Self-citation
The role of dopamine in the maintenance and breakdown of synergism
LaHoste, G. J., & Marshall, J. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91782-n · Cited by 33
Self-citation
Individual and combined effects of ethanol and cocaine on intracellular signals and gene expression
Torres, G., & Horowitz, J. M. (1996) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(96)00034-6 · Cited by 33
Dopamine antagonists induce fos-like-immunoreactivity in the substantia nigra and entopeduncular nucleus of the rat
Wirtshafter, D., & Asin, K. E. (1995) · Brain Research · doi:10.1016/0006-8993(94)01280-u · Cited by 32
Methylmercury induces oxidative stress and subsequent neural hyperactivity leading to cell death through the p38 MAPK-CREB pathway in differentiated SH-SY5Y cells
Fujimura, M., & Usuki, F. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.06.008 · Cited by 31
Genetic Influences on Smoking Behavior and Nicotine Dependence: a Review
Yoshimasu, K., & Kiyohara, C. (2003) · Journal of Epidemiology · doi:10.2188/jea.13.183 · Cited by 30
Prefrontal cortex and basolateral amygdala modulation of dopamine-mediated locomotion in the nucleus accumbens core
Rouillon, C., Abraini, J. H., & David, H. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.04.002 · Cited by 30
Dopamine depresses glutamatergic synaptic transmission in the rat parabrachial nucleus in vitro
Chen, X., Kombian, S. B., Zidichouski, J. A., & Pittman, Q. J. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00594-6 · Cited by 30
The role of the globus pallidus D2 subfamily of dopamine receptors in pallidal immediate early gene expression
Marshall, J. F., Henry, B. L., Billings, L. M., & Hoover, B. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00180-4 · Cited by 29
Self-citation
Cortically driven Fos induction in the striatum is amplified by local dopamine D2‐class receptor blockade
Berretta, S., Sachs, Z., & Graybiel, A. M. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00866.x · Cited by 27
Seeking Brain Biomarkers for Preventive Therapy in Huntington Disease
Esmaeilzadeh, M., Ciarmiello, A., & Squitieri, F. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00157.x · Cited by 25
Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer
Perreault, M. L., Shen, M. Y. F., Fan, T., & George, S. R. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.017 · Cited by 26
Role of nigral NFκB p50 and p65 subunit expression in haloperidol-induced neurotoxicity and stereotyped behavior in rats
Saldaña, M., Bonastre, M., Aguilar, E., & Marı́n, C. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.01.001 · Cited by 26
Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex
Zenko, M., Zhu, Y.-Y., Dremencov, E., Ren, W., Xu, L., & Zhang, X. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22580 · Cited by 25
Monoaminergic Modulation of Cortical Excitability
Tseng, K.-Y., & Atzori, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-72256-6 · Cited by 25
Sites and Mechanisms of Action of Antipsychotic Drugs as Revealed by Immediate-Early Gene Expression
Deutch, A. Y. (1996) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-61007-3_5 · Cited by 25
Differential effect of MK 801 and scopolamine on c‐fos expression induced by L‐dopa in the striatum of 6‐hydroxydopamine lesioned rats
Morelli, M., Pinna, A., Fenu, S., Carta, A. R., Cozzolino, A., & Chiara, G. D. (1994) · Synapse · doi:10.1002/syn.890180403 · Cited by 25
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine
Marti, M., Manzalini, M., Fantin, M., Bianchi, C., Corte, L., & Morari, M. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03015.x · Cited by 24
Dopaminergic control of gene transcription during striatal ontogeny: c-fos induction by D1 receptor activation in the developing striosomes
Arnauld, E., Arsaut, J., Tafani, J. A. M., & Demotes‐Mainard, J. (1995) · Molecular Brain Research · doi:10.1016/0169-328x(95)00011-g · Cited by 24
Brain dopamine receptors--research perspectives and potential sites of regulation.
Dziedzicka‐Wasylewska, M. (2004) · PubMed · Cited by 23
IRIDIUM exposure increases c-fos expression in the mouse brain only at levels which likely result in tissue heating
Morrissey, J. J., Raney, S. R., Heasley, E., Rathinavelu, P., Dauphinée, M. J., & Fallon, J. H. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00091-3 · Cited by 23
Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain
Alonso, R., Gnanadicom, H., Fréchin, N., Fournier, M., Fur, G. L., & Soubrié, P. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00506.x · Cited by 22
Dopamine-D1 and -D2 receptors differentially regulate synapsin II expression in the rat brain
Chong, V. Z., Skoblenick, K. J., Morin, F., Xu, Y., & Mishra, R. K. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.037 · Cited by 21

Authors: LaHoste, G. J., Yu, J., & Marshall, J. F.
Affiliations: University of California, Irvine (US)
ORCID: Yu, J
Marshall, J F
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1993-08-15
Volume: 90
Issue: 16
Pages: 7451-7455
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.90.16.7451
PMC: PMC47159
OpenAlex: W2047619967
Cited by: 182
References: 35
Citations by year: 2023: 2 · 2022: 3 · 2020: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2014: 3 · 2013: 2 · 2012: 4
FWCI: 4.45
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5p50mh044188-05, 1r01ns028846-01)
U.S. Public Health Service
National Institute of Mental Health (MH44188)
National Institute of Neurological Disorders and Stroke (NS22698, NS 28846, R01NS022698)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: c-fos, Fos-like immunoreactivity, dopamine D1 receptor, dopamine D2 receptor, receptor supersensitivity, striatum, caudate-putamen, dopamine agonists, reserpine, dopaminergic denervation, immediate early genes, striatal neurons
MeSH terms: Animals, Corpus Striatum, Drug Synergism, Ergolines, Immunohistochemistry, Male, Reference Values, Reserpine, Dopamine Agents, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Proto-Oncogene Proteins c-fos, Genes, fos, Rats, Sprague-Dawley, Receptors, Dopamine D1, Receptors, Dopamine D2, Quinpirole, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks